Stay updated on Teriflunomide in Pediatric MS Clinical Trial
Sign up to get notified when there's something new on the Teriflunomide in Pediatric MS Clinical Trial page.

Latest updates to the Teriflunomide in Pediatric MS Clinical Trial page
- Check2 days agoChange DetectedA banner announces updates to NIH websites and says NIH content may use “Super Intelligence” alongside “Artificial Intelligence” during a transition.SummaryDifference1%

- Check9 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check16 days agoChange DetectedThe footer’s site revision changed from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check30 days agoChange DetectedThe page now renders a 403 Forbidden error with a Home link, replacing the full study record content and effectively removing the detailed trial information from view.SummaryDifference18%

- Check37 days agoChange DetectedThe page now shows a new revision tag: Revision: v3.7.0. It also removes several indexing/metadata entries (Multiple sclerosis, related topics:, MedlinePlus Genetics) along with the older Revision: v3.6.6, which suggests metadata cleanup rather than changes to substantive study information.SummaryDifference0.1%

- Check44 days agoChange DetectedTel Litwinsky, Israel, 52621 was added as a participating site. Qiryat Krinitzi, Israel, 52621 was removed from the list of study locations.SummaryDifference0.1%

Stay in the know with updates to Teriflunomide in Pediatric MS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Teriflunomide in Pediatric MS Clinical Trial page.